Your browser doesn't support javascript.
loading
Temozolomide treatment of a malignant pheochromocytoma and an unresectable MAX-related paraganglioma.
Ferrara, Alfonso M; Lombardi, Giuseppe; Pambuku, Ardi; Meringolo, Domenico; Bertorelle, Roberta; Nardin, Margherita; Schiavi, Francesca; Iacobone, Maurizio; Opocher, Giuseppe; Zagonel, Vittorina; Zovato, Stefania.
Affiliation
  • Ferrara AM; Departments of Clinical and Experimental Oncology Familial Cancer Clinic and Oncoendocrinology.
  • Lombardi G; Medical Oncology 1.
  • Pambuku A; Medical Oncology 1.
  • Meringolo D; Operative Unit of Endocrinology, Bentivoglio Hospital, Bologna, Italy.
  • Bertorelle R; Immunology and Molecular Oncology Unit.
  • Nardin M; Department of Radiological Sciences and Medical Physics, Radiology Unit.
  • Schiavi F; Departments of Clinical and Experimental Oncology Familial Cancer Clinic and Oncoendocrinology.
  • Iacobone M; Department of Surgery, Oncology and Gastroenterology, Endocrine Surgery Unit, University of Padua, Padua.
  • Opocher G; Department of Medicine, Scientific Direction, Veneto Institute of Oncology IOV-IRCCS.
  • Zagonel V; Medical Oncology 1.
  • Zovato S; Departments of Clinical and Experimental Oncology Familial Cancer Clinic and Oncoendocrinology.
Anticancer Drugs ; 29(1): 102-105, 2018 01.
Article in En | MEDLINE | ID: mdl-29099418

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Paraganglioma / Pheochromocytoma / Adrenal Gland Neoplasms / Dacarbazine Limits: Female / Humans / Male / Middle aged Language: En Journal: Anticancer Drugs Journal subject: ANTINEOPLASICOS Year: 2018 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Paraganglioma / Pheochromocytoma / Adrenal Gland Neoplasms / Dacarbazine Limits: Female / Humans / Male / Middle aged Language: En Journal: Anticancer Drugs Journal subject: ANTINEOPLASICOS Year: 2018 Document type: Article